Physiology and pathology of the blood-brain barrier: implications for microbial pathogenesis, drug delivery and neurodegenerative disorders

References

• Adler WH, Baskar PV, Chrest FJ, Dorsey-Cooper B, Winchurch RA, Nagel JE. HIV infection and aging: mechanisms to explain the accelerated rate of progression in the older patient. Mechanisms of Ageing and Development 1997; 96: 137–155, (Abstract)
   Web of Science ®Google Scholar
• Adler WH, Nagel JE. Acquired immunodeficiency syndrome in the elderly. Drugs and Aging 1994; 4: 410–416, (Abstract)
   PubMed Web of Science ®Google Scholar
• Advokat C, Gulati A. Spinal transection reduces both spinal antinociception and CNS concentration of systemically administered morphine in rats. Brain Res 1991; 555: 251–258
   PubMed Web of Science ®Google Scholar
• Arimura A. Pituitary adenylate cyclase activating polypeptide (PACAP): discovery and current status of research. Regul Pept 1992; 37: 287–303
   PubMedGoogle Scholar
• Audus KL, Chikhale PJ, Miller DW, Thompson SE, Borchardt RT. Brain uptake of drugs: the influence of chemical and biological factors. Advances in Drug Research, B Testa. Academic Press, London 1992; 1–64
   Google Scholar
• Baba M, Oishi R, Saeki K. Enhancement of blood-brain barrier permeability to sodium fluorescein by stimulation of n opioid receptors in mice. Naunyn-Schmied Arch Pharmacol 1988; 37: 423–428
   Google Scholar
• Balin BJ, Broadwell RD, Salcman M, el-Kalliny M. Avenues for entry of peripherally administered protein to the central nervous system in mouse, rat, and squirrel monkey. J Comp Neurol 1986; 251: 260–280
   PubMed Web of Science ®Google Scholar
• Banks WA. Internalization and fusion of HIV-1 gp120 with brain endothelial cells is cAMP dependent. 1999a, In press
   Google Scholar
• Banks WA. Characterization of IL 1α binding to mouse brain endothelial cells. J Pharmacol Exp Ther 1999b, In press
   Google Scholar
• Banks WA, Akerstrom V, Kastin AJ. Adsorptive endocytosis mediates the passage of HIV-1 across the blood-brain barrier: evidence for a post-internalization coreceptor. J Cell Sci 1998; 111: 533–540
   PubMed Web of Science ®Google Scholar
• Banks WA, Broadwell RD. Blood to brain and brain to blood passage of native horseradish peroxidase, wheat germ agglutinin and albumin: pharmacokinetic and morphological assessments. J Neurochem 1994; 62: 2404–2419
   PubMed Web of Science ®Google Scholar
• Banks WA, DiPalma CR, Farrell CL. Impaired transport of leptin across the blood-brain barrier in obesity. Peptides 1999b, in press
   Google Scholar
• Banks WA, Ibrahimi F, Farr SA, Flood JF, Morley JE. Effects of wheatgerm agglutinin and aging on the regional brain uptake of HIV-1 gp120. Life Sci 1999c; 65: 81–89
   Google Scholar
• Banks WA, Kastin AJ. A brain-to-blood carrier-mediated transport system for small, N-tyrosinated peptides. Pharmacol Biochem Behav 1984; 21: 943–946
   PubMed Web of Science ®Google Scholar
• Banks WA, Kastin AJ. Peptides and the blood-brain barrier: lipophilicity as a predictor of permeability. Brain Res Bull 1985; 15: 287–292
   PubMed Web of Science ®Google Scholar
• Banks WA, Kastin AJ. Aging, peptides, and the blood-brain barrier: implications and speculations. Treatment Development Strategies for Alzheimer's Disease, T Crook, R Bartus, S Ferris, S Gershon. Mark Powley Associates, Madison, CT 1986a; 245–265
   Google Scholar
• Banks WA, Kastin AJ. Modulation of the carrier-mediated transport of the Tyr-MIF-1 across the blood-brain barrier by essential amino acids. J Pharmacol Exp Ther 1986b; 239: 668–672
   Google Scholar
• Banks WA, Kastin AJ. The potential for alcohol to affect the passage of peptide and protein hormones across the blood-brain barrier: a hypothesis for a disturbance in brain-body communication. NIAAA Research Monograph 23, Alcohol and the Endocrine System, S Zakhari. National Institutes of Health; National Institute on Alcohol Abuse and Alcoholism, Bethesda, MD 1993a; 401–411
   Google Scholar
• Banks WA, Kastin AJ. Peptide binding in blood and passage across the blood-brain barrier. Proceedings of the International Symposium on Blood Binding and Drug Transfer, JP Tillement, H Eckert, E Albengres, J Barre, P Baumann, F Belpare, M Lemaire. Fort and Clair, Paris 1993b; 223–242
   Google Scholar
• Banks WA, Kastin AJ. Opposite direction of transport across the blood-brain barrier for Tyr-MIF-1 and MIF-1: comparison with morphine. Peptides 1994a; 15: 23–29
   PubMed Web of Science ®Google Scholar
• Banks WA, Kastin AJ. Brain-to-blood transport of peptides and the alcohol withdrawal syndrome. Models of Neuropeptide Action, FL Strand, B Beckwith, B Chronwall, CA Sandman. New York Academy of Sciences, New York 1994b; 108–118
   Google Scholar
• Banks WA, Kastin AJ. The role of the blood-brain barrier transporter PTS-1 in regulating concentrations of methionine enkephalin in blood and brain. Alcohol 1997; 14: 237–245
   PubMedGoogle Scholar
• Banks WA, Kastin AJ. Characterization of lectin-mediated brain uptake of HIV-1 gp120. J Neurosci Res 1998a; 54: 522–529
   PubMed Web of Science ®Google Scholar
• Banks WA, Kastin AJ. Differential permeability of the blood-brain barrier to two pancreatic peptides: Insulin and amylin. Peptides 1998b; 19: 883–889
   PubMed Web of Science ®Google Scholar
• Banks WA, Kastin AJ, Akerstrom V. HIV-1 protein gp120 crosses the blood-brain barrier: role of adsorptive endocytosis. Life Sci 1997b; 61: PL119–PL125
   Google Scholar
• Banks WA, Kastin AJ, Arimura A. Effect of spinal cord injury on the permeability of the blood-brain and blood-spinal cord barriers to the neurotropin PACAP. Exp Neurol 1998; 151: 116–123
   Google Scholar
• Banks WA, Kastin AJ, Brennan JM, Vallance KL. Adsorptive endocytosis of HIV-1 gp120 by blood-brain barrier is enhanced by lipopolysaccharide. Exp Neurol 1999a; 156: 165–171
   PubMed Web of Science ®Google Scholar
• Banks WA, Kastin AJ, Fasold MB. Differential effect of aluminum on the blood-brain barrier transport of peptides, technetium and albumin. J Pharmacol Exp Ther 1988; 244: 579–585
   Google Scholar
• Banks WA, Kastin AJ, Fischman AJ, Coy DH, Strauss SL. Carrier-mediated transport of enkephalins and N-Tyr-MIF-1 across blood-brain barrier. Am J Physiol 1986; 251: E477–E482
   PubMed Web of Science ®Google Scholar
• Banks WA, Kastin AJ, Harrison LM, Zadina JE. Perinatal treatment of rats with opiates affects the development of the blood-brain barrier transport system PTS-1. Neurotoxicol Teratol 1996b; 18: 711–715
   Google Scholar
• Banks WA, Kastin AJ, Huang W, Jaspan JB, Maness LM. Leptin enters the brain by a saturable system independent of insulin. Peptides 1996a; 17: 305–311
   PubMed Web of Science ®Google Scholar
• Banks WA, Kastin AJ, Jaspan JB. Regional variation in transport of pancreatic polypeptide across the blood-brain barrier of mice. Pharmacol Biochem Behav 1995; 51: 139–147
   Google Scholar
• Banks WA, Kastin AJ, Komaki G, Arimura A. Passage of pituitary adenylate cyclase activating polypeptide1–27 and pituitary adenylate cyclase activating polypeptidei1–38 across the blood-brain barrier. J Pharmacol Exp Ther 1993; 267: 690–696
   PubMed Web of Science ®Google Scholar
• Banks WA, Kastin AJ, Rapoport SI. Permeability of the blood-brain barrier to circulating free fatty acids. Handbook of Essential Fatty Acid Biology: Biochemistry, Physiology, and Behavioral Neurobiology, S Yehuda, DI Mostofsky. Human Press, Totowa, NJ 1997a; 3–14
   Google Scholar
• Banks WA, Ortiz L, Plotkin SR, Kastin AJ. Human interleukin (IL) 1α, murine IL-1α and murine IL-1β are transported from blood to brain in the mouse by a shared saturable mechanism. J Pharmacol Exp Ther 1991; 259: 988–996
   PubMed Web of Science ®Google Scholar
• Barrera CM, Kastin AJ, Fasold MB, Banks WA. Bidirectional saturable transport of LHRH across the blood-brain barrier. Am J Physiol 1991; 261: E312–E318
   Google Scholar
• Baura GD, Foster DM, Porte D, Jr, Kahn SE, Bergman RN, Cobelli C, Schwartz MW. Saturable transport of insulin from plasma into the central nervous system of dogs in vivo: a mechanism for regulated insulin delivery to the brain. J Clin Invest 1993; 92: 1824–1830
   PubMed Web of Science ®Google Scholar
• Begley DJ. The interaction of some centrally active drugs with the blood-brain barrier and circum-ventricular organs. Prog Brain Res 1992; 91: 163–169
   PubMed Web of Science ®Google Scholar
• Begley DJ. Strategies for delivery of peptide drugs to the central nervous system: exploiting molecular structure. J Control Release 1994; 29: 293–306
   Web of Science ®Google Scholar
• Betz AL, Goldstein GW. Polarity of the blood-brain barrier: neutral amino acid transport into isolated brain capillaries. Science 1978; 202: 225–227
   PubMed Web of Science ®Google Scholar
• Blasberg RG, Fenstermacher JD, Patlak CS. Transport of α-aminoisobutyric acid across brain capillary and cellular membranes. J Cereb Blood Flow Metab 1983; 3: 8–32
   PubMed Web of Science ®Google Scholar
• Bodnar RJ, Pasternak GW, Mann PE, Paul D, Warren R, Donner DB. Mediation of anorexia by human recombinant tumor necrosis factor through a peripheral action in the rat. Cancer Res 1989; 15: 6280–6284
   Google Scholar
• Bourinbaiar AS, Phillips DM. Transmission of human immunodeficiency virus from monocytes to epithelia. J Acquir Immune Defic Syndr 1991; 4: 56–63
   PubMed Web of Science ®Google Scholar
• Bradbury M. The Concept of a Blood-Brain Barrier. John Wiley and Sons Ltd, New York 1979
   Google Scholar
• Broadwell RD. Transcytosis of macromolecules through the blood-brain barrier: a cell biological perspective and critical appraisal. Acta Neuropathol. (Berl) 1989; 79: 117–128
   PubMed Web of Science ®Google Scholar
• Broadwell RD. Endothelial cell biology and the enigma of transcytosis through the blood-brain barrier. Adv Exp Med Biol 1993; 331: 137–141
   Google Scholar
• Broadwell RD, Balin BJ, Salcman M. Transcytotic pathway for blood-borne protein through the blood-brain barrier. Proc Natl. Acad. Sci USA 1988; 85: 632-–636
   PubMed Web of Science ®Google Scholar
• Broadwell RD, Banks WA. Cell biological perspective for the transcytosis of peptides and proteins through the mammalian blood-brain fluid barriers. The Blood-Brain Barrier, WM Pardridge. Raven Press Ltd, New York 1993; 165–199
   Google Scholar
• Broadwell RD, Salcman M. Expanding the definition of the blood-brain barrier to protein. Proc Natl. Acad Sci. USA 1981; 78: 7820–7824
   PubMed Web of Science ®Google Scholar
• Broadwell RD, Sofroniew MV. Serum proteins bypass the blood-brain barrier for extracellular entry to the central nervous system. Exp Neurol 1993; 120: 245–263
   PubMed Web of Science ®Google Scholar
• Bulat M, Zivkovic B. Neurochemical study of the cerebrospinal fluid. Research Methods in Neuro-chemistry, N Marks, R Rodnight. Plenum Press, New York 1978; Volume 4: 57–89
   Google Scholar
• Büttner A, Mehraein P, Weis S. Vascular changes in the cerebral cortex in HIV-1 infection. Acta Neuropathol 1996; 92: 35–41
   PubMed Web of Science ®Google Scholar
• Caro JF, Kolaczynski JW, Nyce MR, Ohannesian IP, Opentanova I, Goldman WH, Lynn RB, Zhang P-L, Sinha MD, Considine RV. Decreased cerebro-spinal-fluid/serum leptin ratio in obesity: a possible mechanism for leptin resistance. Lancet 1996; 348: 159–161
   PubMed Web of Science ®Google Scholar
• Cashion MF, Banks WA, Bost KL, Kastin AJ. Transmission routes of HIV-1 gp120 from brain to lymphoid tissues. Brain Res 1999; 822: 26–33
   Google Scholar
• Chen G, Castro WL, Chow H-H, Reichlin S. Clearance of 125I-labelled interleukin-6 from brain into blood following intracerebroventricular injection in rats. Endocrinology 1997; 138: 4830–4836
   Google Scholar
• Chikale EG, Burton PS, Borchardt RT. The effect of verapamil on the transport of peptides across the blood-brain barrier in rats: kinetic evidence for an apically polarized efflux mechanism. J Pharmacol Exp Ther 1995; 273: 298–303
   Google Scholar
• Chikhale EG, Ng KY, Burton PS, Borchardt RT. Hydrogen bonding potential as a determinant of the in vitro and in situ blood-brain barrier permeability of peptides. Pharm Res 1994; 11: 412–419
   PubMed Web of Science ®Google Scholar
• Chin Y-H, Sackstein R, Cai J-P. Lymphocyte-homing receptors and preferential migration pathways. Proc Soc Exp Biol Med 1991; 196: 374–380
   Google Scholar
• Cordon-Cardo C, O'Brien JP, Casals D, Rittman-Grauer L, Biedler JL, Melamed MR, Bertino JR. Multi-drug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites. Proc Natl Acad Sci USA 1989; 86: 695–698
   PubMed Web of Science ®Google Scholar
• Cornford EM, Braun LD, Oldendorf WH, Hill MA. Comparison of lipid-mediated blood-brain-barrier penetrability in neonates and adults. Am J Physiol 1982; 243: C161–C168
   PubMed Web of Science ®Google Scholar
• Cserr HF, Knopf PM. Cervical lymphatics, the blood-brain barrier and the immunoreactivity of the brain: a new view. Immunol Today 1992; 13: 507–512
   PubMedGoogle Scholar
• Daniel PM, Love ER, Pratt OE. The effect of age upon the influx of glucose into the brain. J Physiol (London) 1978; 274: 141–148
   Google Scholar
• Davson H. The blood-brain barrier. AnonymousPhysiology of the Cerebrospinal Fluid. J and A Churchill Ltd, London 1967; 82–103
   Google Scholar
• Davson H, Hollingsworth JG, Carey MB, Fenstermacher JD. Ventriculo-cisternal perfusion of twelve amino acids in the rabbit. J Neurobiol 1982; 13: 293–318
   Google Scholar
• Davson H, Segal MB. The return of the cerebrospinal fluid to the blood: The drainage mechanism. Anonymous Physiology of the CSF and Blood-Brain Barriers. CRC Press, Boca Raton 1996a; 489–523
   Google Scholar
• Davson H, Segal MB. Morphological aspects of the barriers. AnonymousPhysiology of the CSF and Blood-Brain Barriers. CRC Press, Boca Raton 1996b; 93–192
   Google Scholar
• Davson H, Segal MB. The proteins and other macromolecules of the CSF. Anonymous Physiology of the CSF and the Blood-Brain Barriers. CRC Press, Boca Raton 1996c; 573–606
   Google Scholar
• Davson H, Segal MB. Special aspects of the blood-brain barrier. Anonymous Physiology of the CSF and Blood-Brain Barriers. CRC Press, Boca Raton 1996d; 303–485
   Google Scholar
• de la Torre JC, Mussivant T. Can disturbed brain microcirculation cause Alzheimer's disease?. Neurological Research 1993; 15: 146–153
   PubMed Web of Science ®Google Scholar
• de Lange EC, Bouw MR, Mandema JW, Danhof M, De Boer AG, Breimer DD. Application of intracerebral microdialysis to study regional distribution kinetics of drugs in rat brain. Br J Pharmacol 1995; 2538–2544
   Google Scholar
• De Vivo DC, Triflletti RR, Jacobson RI, Ronen GM, Behmand RA, Harik SI. Defective glucose transport across the blood-brain barrier as a cause of persistent hypoglycorrhachia, seizures, and developmental delay. N Engl J Med 1991; 325: 703–709
   PubMed Web of Science ®Google Scholar
• Defazio G, Trojano M, Ribatti D, Nico B, Giorelli M, De Salvia R, Russo G, Roncali L, Livrea P. ICAM 1 expression and fluid phase endocytosis of cultured brain microvascular endothelial cells following exposure to interferon beta-la and TNFalpha. J Neuroimmunol 1998; 88: 13–20
   Google Scholar
• Donaldson YK, Bell JE, Ironside JW, Brettle RP, Robertson JR, Busuttil A, Simmonds P. Redistribution of HIV outside the lymphoid system with onset of AIDS. Lancet 1994; 343: 383–385
   Google Scholar
• Dorheim M-A, Tracey WR, Pollock JS, Grammas P. Nitric oxide synthase activity is elevated in brain microvessels in Alzheimer's disease. Biochem Biophys Res Commun 1994; 205: 659–665
   PubMed Web of Science ®Google Scholar
• Drewes LR, Conway WP, Gilboe DD. Net amino acid transport between plasma and erythrocytes and perfused dog brain. Am J Physiol 1977; 2: E320–E325
   Google Scholar
• Drion N, Lemaire M, Lefauconnier JM, Scherrmann J-M. Role of p-glycoprotein in the blood-brain transport of colchicine and vinblastine. J Neurochem 1996; 67: 1688–1693
   PubMed Web of Science ®Google Scholar
• Duffy KR, Pardridge WM. Blood-brain barrier transcytosis of insulin in developing rabbits. Brain Res 1987; 420: 32–38
   PubMed Web of Science ®Google Scholar
• Dux E, Doczi T, Joo F, Szerdahelyi P, Siklos L. Reverse pinocytosis induced in cerebral endothelial cells by injection of histamine into the cerebral ventricle. Acta Neuropathol (Berl) 1988; 76: 484–488
   Google Scholar
• Feng Y, Broder CC, Kennedy PE, Berger EA. HIV-1 entry cofactor: function cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science 1996; 272: 872–877
   PubMed Web of Science ®Google Scholar
• Ferro S, Salit IE. HIV infection in patients over 55 years of age. J Acquir Immune Defic Syndr 1992; 5: 348–353, (Abstract)
   PubMed Web of Science ®Google Scholar
• Fiala AM, Gan XH, Newton T, Chiappelli F, Shapshak P, Kermaini V, Kung MA, Diagne A, Martinez O, Way D, Weinand M, Witte M, Graves M. Divergent effects of cocaine on cytokine production by lymphocytes and monocyte/macrophages: HIV-1 enhancement by cocaine within the blood-brain barrier. Adv Exp Med Biol 1996; 402: 145–156
   Google Scholar
• Fiala M, Looney DJ, Stins M, Way DD, Zhang L, Gan X, Chiappelli F, Schweitzer ES, Shapshak P, Weinand M, Graves MC, Witte M, Kim KS. TNF-α opens a paracellular route for HIV-1 invasion across the blood-brain barrier. Molecular Medicine 1997; 3: 553–564
   PubMed Web of Science ®Google Scholar
• Friedman JM, Halaas JL. Leptin and the regulation of body weight in mammals. Nature 1998; 395: 763–770
   PubMed Web of Science ®Google Scholar
• Frigerio S, Gelati M, Ciusani E, Corsini E, Dufour A, Massa G, Salmaggi A. Immunocompetence of human microvascular brain endothelial cells: cytokine regulation of IL-1beta, MCP-1, IL-10, sICAM-1 and sVCAM-1. J Neurol 1998; 245: 727–730
   Google Scholar
• Gilat D, Hershkoviz R, Mekori YA, Vlodavsky I, Lider O. Regulation of adhesion of CD4+ T lymphocytes to intact or heparinase-treated subendothelial extracellular matrix by diffusible or anchored RANTES and MIP-1 beta. J Immunol 1994; 153: 4899–4906
   PubMed Web of Science ®Google Scholar
• Glynn SL, Yazdanian M. In vitro blood-brain barrier permeability of nevirapine compared to other HIV antiretroviral agents. J Pharm Sci 1998; 87: 306–310
   PubMed Web of Science ®Google Scholar
• Gonindard C, Goigoux C, Hollande E, D'Hinterland LD. The administration of an alpha-MSH analogue reduces the serum release of IL-1 alpha and TNF alpha induced by the injection of a sublethal dose of lipopolysaccharides in the BALB/c mouse. Pigment Cell Res 1996; 9: 148–153
   Google Scholar
• Grammas P, Moore P, Botchlet T, Hanson-Painton O, Cooper DR, Ball MJ, Roher A. Cerebral microvessels in Alzheimer's have reduced protein kinase C activity. Neurobiol Aging 1995; 16: 563–569
   Google Scholar
• Grammas P, Moore P, Weigel PH. Microvessels from Alzheimer's disease brains kill neurons in vitro. Am J Pathol 1999; 154: 337–342
   PubMed Web of Science ®Google Scholar
• Grammas P, Toya R, Botchlet TR, Moore P, Weigel PH. Production of neurotoxic factors by brain endothelium in Alzheimer's disease. Cerebrovascular Pathology in Alzheimer's Disease, JC de la Torre, V. Hachinski. Annals of the New York Academy of Sciences (GENERIC), New York 1997; 826: 47–55, Ref type: Serial (Book, Monograph)
   Google Scholar
• Greenwood J, Pratt OE. The effect of ethanol upon thiamine transport across the blood-brain barrier in the rat. J Physiol (London) 1983; 348: 61P
   Google Scholar
• Hansson HA, Johansson B, Blomstrand C. Ultrastructural studies on cerebrovascular permeability in acute hypertension. Acta Neuropathol 1975; 32: 187–198
   PubMed Web of Science ®Google Scholar
• Hardebo JE, Kahrstrom J. Endothelial negative surface charge areas and blood-brain barrier function. Acta Physiol Scand 1985; 125: 495–499
   PubMedGoogle Scholar
• Harik SI, Kalaria RN. Blood-brain barrier abnormalities in Alzherimer's disease. Ann NY Acad Sci 1991; 640: 47–52
   Google Scholar
• Harrison LM, Zadina JE, Banks WA, Kastin AJ. Effects of neonatal treatment with Tyr-MIF-1, morphiceptin, and morphine on development, tail flick, and blood-brain barrier transport. Dev Brain Res 1993; 75: 207–212
   Google Scholar
• Ha worth SJ, Christofalo B, Anderson RD, Dunkle LM. A single-dose study to assess the penetration of stavudine into human cerebrospinal fluid in adults. J Acquir Immune Defic Syndr Human Retrovir 1998; 17: 235–238
   Google Scholar
• Hernandez LD, Hoffman LR, Wolfsber TG, White JM. Virus-cell and cell-cell fusion. Annual Review of Cell and Developmental Biology 1996; 12: 627–661
   PubMed Web of Science ®Google Scholar
• Johanson CE. The choroid plexus-arachnoid membrane-cerebrospinal fluid system. Neuronal Microenvironment, AA Boulton, GB Baker, W Walz. The Humana Press, Clifton, New Jersey 1988; 33–104
   Google Scholar
• Johansson BB. Hypertension and the blood-brain barrier. Implications of the Blood-Brain Barrier and its Manipulation. Vol 2. Clinical Aspects, EA Neuwelt. Plenum Publishing Co, New York 1989; 389–410
   Google Scholar
• Johnson AK, Gross PM. Sensory circumventricular organs and brain homeostatic pathways. FASEB J 1993; 7: 678–686
   PubMed Web of Science ®Google Scholar
• Kakee A, Terasaki T, Sugiyama Y. Brain efflux index as a novel method of analyzing efflux transport at the blood-brain barrier. J Pharmacol Exp Ther 1996; 277: 1550–1559
   PubMed Web of Science ®Google Scholar
• Kalomiris EL, Bourguignon LY. Mouse T lymphoma cells contain a transmembrane glycoprotein (GP85) that binds ankyrin. J Cell Biol 1988; 106: 319–327
   PubMed Web of Science ®Google Scholar
• Kety SS. Cerebral circulation and its measurement by inert diffusible tracers. Encyclopedia of Neuroscience, G Adelman. Birkhauser, Boston 1987; Volume 1: 206–208
   Google Scholar
• Kim RB, Fromm MF, Wandel C, Leake B, Wood A JJ, Roden DM, Wilkinson GR. The drug transporter p-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors. J Clin Invest 1999; 101: 289–294
   Google Scholar
• Kimura C, Ohkubo S, Ogi K, Hosoya M, Itoh Y, Onda H, Miyata A, Jiang L, Dahl RR, Stibbs HH, Arimura A, Fujino M. A novel peptide which stimulates adenylate cyclase: molecular cloning and characterization of the ovine and human cDNAs. Biochem Biophys Res Commun 1990; 166: 81–89
   PubMed Web of Science ®Google Scholar
• Knopf PM, Cserr HF, Nolan SC, Wu T-Y, Harling-Berg CJ. Physiology and immunology of lymphatic drainage of interstitial and cerebrospinal fluid from the brain. Neuropathology and Applied Neurobiology 1995; 21: 175–180
   PubMed Web of Science ®Google Scholar
• Komura J, Tamai I, Senmaru M, Terasaki T, Sai Y, Tsuji A. Brain-to-blood active transport of β-alanine across the blood-brain barrier. FEBS Lett 1997; 400: 131–135
   Google Scholar
• Krisch B, Leonhardt H. Relations between leptomeningeal compartments and the neurohemal regions of circumventricular organs. Biomed Res 1989; 10: 155–168, (Suppl 3)
   Google Scholar
• Laye S, Parnet P, Goujon E, Dantzer R. Peripheral administration of lipopolysaccharide induces the expression of cytokine transcripts in the brain and pituitary of mice. Brain Bes 1994; 27: 157–162
   Google Scholar
• Lee C GL, Gottesman MM, Cardarelli CO, Ramachandra M, Jeang K-T, Ambudkar SV, Pastan I, Dey S. HIV-1 protease inhibitors are substrates for the MDR1 multidrug transporter. Biochemistry 1998; 37: 3594–3601
   PubMed Web of Science ®Google Scholar
• Lehto VP, Virtanen I. Immunolocalization of a novel, cytoskeleton-associated polypeptide of Mr 230,000 daltons (p230). J Cell Biol 1983; 96: 703–716
   PubMedGoogle Scholar
• Levin VA. Relationship of octanol/water partition coefficient and molecular weight to rat brain capillary permeability. Journal of Medicinal Chemistry 1999; 23: 683–685
   Google Scholar
• Lossinsky AS, Pluta R, Song MJ, Badmajew V, Moretz RC, Wisniewski HM. Mechanisms of inflammatory cell attachment in chronic relapsing experimental allergic encephalomyelitis: a scanning and high-voltage electron microscopy study of the injured mouse blood-brain barrier. Microvasc Res 1991; 41: 299–310
   Google Scholar
• Lossinsky AS, Vorbrodt AW, Wisniewski HM. Ultracytochemical studies of vesicular and canalicular transport structures in the injured mammalian blood-brain barrier. Acta Neuropathol (Berl) 1983; 61: 239-–245
   PubMed Web of Science ®Google Scholar
• Male D. The blood-brain barrier- No barrier to a determined lymphocyte. New Concepts of a Blood-Brain Barrier, J Greenwood, DJ Begley, MB Segal. Plenum Press, New York 1995; 311–314
   Google Scholar
• Mandi Y, Ocsovszki I, Szabo D, Nagy Z, Nelson J, Molnar J. Nitric oxide production and MDR expression by human brain endothelial cells. Anticancer Research 1998; 18: 3049–3052
   PubMed Web of Science ®Google Scholar
• Maness LM, Banks WA, Zadina JE, Kastin AJ. Selective transport of blood-borne interleukin-1α into the posterior division of the septum of the mouse brain. Brain Res 1995; 700: 83–88
   PubMed Web of Science ®Google Scholar
• Maness LM, Kastin AJ, Banks WA. Relative contributions of a CVO and the microvascular bed to delivery of blood-borne IL-1α to the brain. Am J Physiol 1998; 275: E207–E212
   Google Scholar
• Marsh M. The entry of enveloped viruses into cells by endocytosis. Biochem J 1984; 218: 1–10
   PubMed Web of Science ®Google Scholar
• Martins JM, Banks WA, Kastin AJ. Acute modulation of the active carrier-mediated brain to blood transport of corticotropin-releasing hormone. Am J Physiol 1997a; 272: E312–E319
   PubMed Web of Science ®Google Scholar
• Martins JM, Banks WA, Kastin AJ. Transport of CRH from mouse brain directly affects peripheral production of β-endorphin by the spleen. Am J Physiol 1997b; 273: E1083–E1089
   Google Scholar
• Masereeuw R, Jaehde U, Langemeijer M WE, De Boer AG, Breimer DD. In vivo and in vitro transport of zidovudine (AZT) across the blood-brain barrier and the effects of transport inhibitors. Pharm Res 1994; 11: 324–330
   PubMed Web of Science ®Google Scholar
• Mayhan WG, Heistad DD. Permeability of the blood-brain barrier to various sized molecules. Am J Physiology 1985; 248: H712–H718
   PubMedGoogle Scholar
• McQuay HJ, Sullivan AF, Smallman K, Dickenson AH. Intrathecal opioids, potency and lipophilicity. Pain 1989; 36: 111–115
   PubMed Web of Science ®Google Scholar
• Mehta R, Zingde S, Advani S, Desai H, Gothoskar B. Protein la: a major wheat germ agglutinin binding protein on the surface of human granulocytes associated with the cytoskeleton. Mol Cell Biochem 1999; 144: 153–165
   Google Scholar
• Mooradian AD, Morin AM, Cipp LJ, Haspel HC. Glucose transport is reduced in the blood-brain barrier of aged rats. Brain Res 1991; 551: 145–149
   Google Scholar
• Moses AV, Bloom FE, Pauza CD, Nelson JA. Human immunodeficiency virus infection of human brain capillary endothelial cells occurs via a CD4/galactosylceramide-independent mechanism. Proc Natl Acad Sci USA 1993; 90: 10474–10478
   PubMed Web of Science ®Google Scholar
• Murray CL, Quaglia M, Arnason JT, Morris CE. A putative nicotine pump at the metabolic blood-brain barrier of the tobacco hornworm. J Neurobiol 1994; 25: 23–34
   PubMedGoogle Scholar
• Murray JE, Cutler R WP. Transport of glycine from the cerebrospinal fluid: Factors regulating amino acid concentration in feline cerebrospinal fluid. Arch Neurol 1970; 23: 23–31
   Google Scholar
• Nelson PK, Masters LT, Zagzag D, Kelly PJ. Angiographic abnormalities in progressive multifocal leukoencephalopathy: an explanation based on neuro-pathologic findings. American Journal of Neuroradiology 1999; 20: 487–494
   Google Scholar
• Nottet HS, Persidsky Y, Sasseville VG, Nukuna AN, Bock P, Zhai QH, Sharer LR, Mc Comb RD, Swindells S, Soderland C, Gendelman HE. Mechanisms for the transendothelial migration of HIV-1-infected monocytes into brain. J Immunol 1996; 156: 1284–1295
   PubMed Web of Science ®Google Scholar
• Ogle CK, Ogle JD, Hartmann S, Szczur K, Guo X. Production of tumor necrosis factor, interleukin-6 and prostaglandin E2 by LPS-stimulated rat bone marrow macrophages after thermal injury: effect of indomethacin. Inflammation 1994; 18: 175–185
   Google Scholar
• Oldendorf WH. Brain uptake of radio-labelled amino acids, amines and hexoses after arterial injection. Am J Physiol 1971; 221: 1629–1639
   PubMed Web of Science ®Google Scholar
• Oldendorf WH. Lipid solubility and drug penetration of the blood-brain barrier. Proc Soc Exp Biol Med 1974; 147: 813–816
   PubMed Web of Science ®Google Scholar
• Pan W, Banks WA, Kastin AJ. BBB permeability to ebiratide and TNF in cute spinal cord injury. Exp Neurol 1997; 146: 367–373
   PubMed Web of Science ®Google Scholar
• Pan W, Banks WA, Kennedy MK, Gutierrez EG, Kastin AJ. Differential permeability of the BBB in acute EAE: enhanced transport of TNF-α. Am J Physiol 1996; 271: E636–E642
   PubMed Web of Science ®Google Scholar
• Passaro E, Jr, Debas H, Oldendorf W, Yamada T. Rapid appearance of intraventricularly administered neuropeptides in the peripheral circulation. Brain Res 1982; 241: 338–340
   Google Scholar
• Patlak CS, Blasberg RG, Fenstermacher JD. Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. J Cereb Blood Flow Metab 1983; 3: 1–7
   PubMed Web of Science ®Google Scholar
• Persidsky Y, Stins M, Way D, Witte MH, Weinand M, Kim KS, Bock P, Gendelman HE, Fiala M. A model for monocyte migration through the blood-brain barrier during HIV-1 encephalitis. J Immunol 1997; 158: 3499–3510
   PubMed Web of Science ®Google Scholar
• Pettipher ER, Wimberly DJ. Cyclooxygenase inhibitors enhance tumor necrosis factor production and mortality in murine endotoxic shock. Cytokine 1994; 6: 500–503
   Google Scholar
• Phillips AN, Lee CA, Elford J, Webster A, Janossy G, Timms A, Bofill M, Kernoff PB. More rapid progression to AIDS in older HIV-infected people: role of CD4+ T-cell counts. J Acquir Immune Defic Syndr 1991; 4: 970–975, (Abstract)
   PubMed Web of Science ®Google Scholar
• Pleskoff O, Treboute C, Brelot A, Heveker N, Seman M, Alizon M. Identification of a chemokine receptor encoded by human cytomegalovirus as a cofactor for HIV-1 entry. Science 1997; 276: 1874–1878
   PubMed Web of Science ®Google Scholar
• Plotkin SR, Banks WA, Waguespack PJ, Kastin AJ. Ethanol alters the concentration of met-enkephalin in brain by affecting peptide transport system-1 independent of preproenkephalin mRNA. J Neurosci Res 1997; 48: 273–280
   Google Scholar
• Qin Y, Sato TN. Mouse multidrug resistance la/3 gene is the earliest known endothelial cell differentiation marker during blood-brain barrier development. Dev Dynamics 1995; 202: 172–180
   PubMed Web of Science ®Google Scholar
• Raeissi S, Audus KL. In-vitro characterization of blood-brain barrier permeability to delta sleep-inducing peptide. Ann NY Acad Sci 1989; 41: 848–852
   Google Scholar
• Rapoport SI. Blood Brain Barrier in Physiology and Medicine. Raven Press, New York 1976
   Google Scholar
• Reed DJ, Woodbury DM, Jacobs L, Squires R. Factors affecting distribution of iodide in brain and cerebrospinal fluid. Am J Physiol 1965; 209: 757–764
   PubMedGoogle Scholar
• Reese TS, Brightman MW. Similarity in structure and permeability to peroxidase of epithelia overlying fenestrated cerebral capillaries. Anat Record 1968; 160: 414, (Abstract)
   Google Scholar
• Romero LI, Lldiko K, Lechan RM, Reichlin S. Interluekin-6 (IL-6) is secreted from the brain after intracerebroventricular injection of IL-1β in rats. Am J Physiol 1996; 270: R518–R524
   Google Scholar
• Rottenberg DA, Sidtis JJ, Strother SC, Schaper KA, Anderson JR, Nelson MJ, Price RW. Abnormal cerebral glucose metabolism in HIV-1 seropositive subjects with and without dementia. J Nucl Med 1996; 37: 1133–1141
   PubMed Web of Science ®Google Scholar
• Sakata A, Tamai I, Kawazu K, Deguchi Y, Ohnishi T, Saheki A, Tsuji A. In vivo evidence for ATP-dependent and p-glycoprotein-mediated transport of cyclosporin A at the blood-brain barrier. Biochem Pharmacol 1994; 48: 1989–1992
   PubMed Web of Science ®Google Scholar
• Saland LC, Van Epps DE, Ortiz E, Samora A. Acute injections of opiate peptides into the rat cerebral ventricle: a macrophage-like cellular response. Brain Res Bull 1983; 10: 523–528
   Google Scholar
• Salmivirta M, Lidholt K, Lindahl U. Heparan sulfate: a piece of information. FASEB J 1996; 10: 1270–1279
   PubMed Web of Science ®Google Scholar
• Schinkel AH, Smit J IM, van Tellingen O, Beijnen JH, Wagenaar E, van Deemter L, Mol C AAM, van der Valk MA, Robanus-Maandag EC, te Riele H PJ, Berns A JM, Borst P. Disruption of the mouse mdrla p-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs. Cell 1994; 77: 491–502
   PubMed Web of Science ®Google Scholar
• Schinkel AH, Wagenaar E, Mol C AAM, van Deemter L. P-Glycoprotein in the blood-brain barrier of mice influences the brain penetration and pharmacological activity of many drugs. J Clin Invest 1996; 97: 2517–2524
   PubMed Web of Science ®Google Scholar
• Schwartz MW, Peskind E, Raskind M, Boyko EJ, Porte D, Jr. Cerebrospinal fluid leptin levels: relationship to plasma levels and adiposity in humans. Nature Medicine 1996; 2: 589–593
   PubMed Web of Science ®Google Scholar
• Sharief MK, Noori MA, Ciardi M, Cirelli A, Thompson EJ. Increased levels of circulating ICAM-1 in serum and cerebrospinal fluid of patients with active multiple sclerosis. Correlation with TNF-α and blood-brain barrier damage. J Neuroimmunol 1993; 43: 15–22
   PubMed Web of Science ®Google Scholar
• Shaw KT, Greig NH. Chemokine receptor mRNA expression at the in vitro blood-brain barrier during HIV infection. Neuroreport 1999; 10: 53–56
   Google Scholar
• Shimura T, Tabata S, Ohnishi T, Terasaki T, Tsuji A. Transport mechanism of a new behaviorally highly potent adrenocorticotropic hormone (ACTH) analog, ebiratide, through the blood-brain barrier. J Pharmacol Exp Ther 1991; 258: 459–465
   PubMed Web of Science ®Google Scholar
• Sjölander A, Magnusson K-E. Effects of wheat germ agglutinin on the cellular content of filamentous actin in Intestine 407 cells. Eur J Cell Biol 1988; 47: 32–35
   PubMedGoogle Scholar
• Snodgrass SR, Cutler R WP, Kang ES, Lorenzo AV. Transport of neutral amino acids from feline cerebrospinal fluid. Am J Physiol 1969; 217: 974–980
   PubMed Web of Science ®Google Scholar
• Spector R. Ceftriaxone transport through the blood-brain barrier. J Infect Dis 1987; 156: 209–211
   Google Scholar
• Spector R, Lorenzo AV. The effects of salicylate and probenecid on the cerebrospinal fluid transport of penicillin, aminosalicylic acid and iodide. J Pharmacol Exp Ther 1974; 188: 55–65
   PubMed Web of Science ®Google Scholar
• Spiegelman BM, Flier JS. Adipogenesis and obesity: rounding out the big picture. Cell 1996; 87: 377–389
   PubMed Web of Science ®Google Scholar
• Suchard SJ, Boxer LA. Characterization and cytoskeletal association of a major cell surface glycoprotein, GP 140, in human neutrophils. J Clin Invest 1989; 84: 484–492
   PubMed Web of Science ®Google Scholar
• Takasato Y, Rapoport SI, Smith QR. An in situ brain perfusion technique to study cerebrovascular transport in the rat. Am J Physiol 1984; 247: H484–H493
   PubMed Web of Science ®Google Scholar
• Takasawa M, Terasaki T, Suzuki H, Ooie T, Sugiyama Y. Distributed model analysis of 3′-azido-3′deox-ythymidine and 2′,3′-dideoxyinosine across the blood-brain barrier via a probenecid-sensitive transport system. J Pharmacol Exp Ther 1997a; 282: 1509–1517
   PubMed Web of Science ®Google Scholar
• Takasawa M, Terasaki T, Suzuki H, Sugiyama Y. In vivo evidence for carrier-mediated efflux transport of 3′azido-3′deoxythymidine and 2′,3′-dideoxyinosine across the blood-brain barrier via a probenecid-sensitive transport system. J Pharmacol Exp Ther 1997b; 281: 369–375
   PubMed Web of Science ®Google Scholar
• Tamaru M, Tomura K, Sakamoto S, Tezuka K, Tamatani T, Narumi S. Interleukin-1beta induces tissue-and cell type-specific expression of adhesion molecules in vivo. Arterioscl Throm Vase Biol 1998; 18: 1292–1303
   PubMed Web of Science ®Google Scholar
• Tavassoli M, Minguell JJ. Homing of hemopoietic progenitor cells to the marrow. Proc Soc Exp Biol Med 1991; 196: 367–373
   PubMed Web of Science ®Google Scholar
• Tenner-Racz K, Stellbrink HJ, van Lunzen J, Schneider C, Jacobs JP, Raschdorff B, Grosschupff G, Steinman RM, Racz P. The unenlarged lymph nodes of HIV-1-infected, asymptomatic patients with high CD4 T cell counts are sites for virus replication and CD4 T cell proliferation. The impact of highly active antiretroviral therapy. J Exp Med 1998; 187: 949–959
   Google Scholar
• Teraski T, Pardridge WM. Restricted transport of 3′-azido-3′-deoxythymidine and 2′-3′-dideoxynucleo-sides through the blood-brain barrier. Journal of Infectious Diseases 1988; 158: 630–632
   Google Scholar
• Terasaki T, Takakuwa S, Saheki A, Moritani S, Shimura T, Tabata S, Tsuji A. Absorptive-mediated endocytosis of an adrenocorticotropic hormone (ACTH) analogue, ebiratide, into the blood-brain barrier: studies with monolayers of primary cultured bovine brain capillary endothelial cells. Pharm Res 1992; 9: 529–534
   PubMed Web of Science ®Google Scholar
• Terracina L, De Medio GE, Trovarelli G, Gaiti A. Phospholipid base-exchange in brain microvessels. Italian Journal of Biochemistry 1994; 43: 151–156
   Google Scholar
• Thompson SE, Audus KL. Leucine enkephalin effects on brain microvessel endothelial cell monolayer permeability. Pharm Res 1994; 11: 1366–1369
   Google Scholar
• Thompson SE, Cavitt J, Audus KL. Leucine enkephalin effects on paracellular and transcellular permeation pathways across brain microvessel endothelial cell monolayers. J Cardiovasc Pharmacol 1994; 24: 818–825
   Google Scholar
• Ting P, Xu S, Krumins S. Endogenous opioid system activity following temporary focal cerebral ischemia. Acta Neurochir Suppl (Wien) 1994; 60: 253–256
   Google Scholar
• Tsuji A, Tamai I. Blood-brain barrier function of P-glycoprotein. Advanced Drug Delivery Reviews 1997; 25: 287–298
   Web of Science ®Google Scholar
• Tsuji A, Tamai I, Sakata A, Tenda Y, Terasaki T. Restricted transport of cyclosporin A across the blood-brain barrier by a multidrug transporter, P-glycoprotein. Biochem Pharmacol 1993; 46: 1096–1099
   PubMed Web of Science ®Google Scholar
• Tsuji A, Terasaki T, Takabatake Y, Tenda Y, Tamai I, Yamashima T, Moritani S, Tsuruo T, Yamashita J. P-glycoprotein as the drug efflux pump in primary cultured bovine brain capillary endothelial cells. Life Sci 1992; 51: 1427–1437
   PubMed Web of Science ®Google Scholar
• Uchida D, Arimura A, Somogyvari-Vigh A, Shioda S, Banks WA. Prevention of ischemia-induced death of hippocampal neurons by pituitary adenylate cyclase activating polypeptide. Brain Res 1996; 736: 280–286
   Google Scholar
• Uchida D, Shloda S, Takaki A, Arimura A. Cytoprotective action of pituitary adenylate cyclase activating polypeptide (PACAP) in ischemia-induced neuronal cell death in rat hippocampus. Soc Neurosci Abstr 1994; 193(10)442, (Abstract)
   Google Scholar
• Vann JM, Goldman AJ, Szurek PF, Brooks BR. Deoxyglucose uptake by mouse astrocytes: Effects of temperature and retrovirus infection. Neurochem Res 1999; 20: 1013–1020
   Google Scholar
• Villegas JC, Broadwell RD. Transcytosis of protein through the mammalian cerebral epithelium and endothelium: II. Adsorptive transcytosis of WGA-HRP and the blood-brain and brain-blood barriers. J Neurocytol 1993; 22: 67–80
   PubMedGoogle Scholar
• Vorbrodt AW. Glycoconjugates and anionic sites in the blood-brain barrier. Glycobiology and the Brain, M Nicolini, PF Zatta. Pergamon Press, Oxford 1994; 37–62
   Google Scholar
• Wang Y, Sawchuck RJ. Zidovudine transport in the rabbit brain during intravenous and intracerebro-ventricular infusion. J Pharm Sci 1995; 4: 871–876
   Google Scholar
• Weber SJ, Abbruscato TJ, Brownson EA, Lipkowski AW, Polt R, Misicka A, Haaseth RC, Bartosz H, Hruby VJ, Davis TP. Assessment of an in vitro blood-brain barrier model using several [Met5]enkephalin opioid analogs. J Pharmacol Exp Ther 1993; 266: 1649–1655
   PubMed Web of Science ®Google Scholar
• Weindl A. Neuroendocrine aspects of circumventricular organs. Frontiers in Neuroendocrinology, WF Ganong, L Martini. Oxford University Press, New York 1973; 3–32
   Google Scholar
• Westergren I, Johansson BB. Altering the blood-brain barrier in the rat by intracarotid infusion of polycations: a comparison between protamine, poly-L-lysine and poly-L-arginine. Acta Physiol Scand 1993; 149: 99–104
   PubMedGoogle Scholar
• Wiley CA, Schrier RD, Nelson JA, Lampert PW, Oldstone M BA. Cellular localization of human immunodeficiency virus infection within the brains of acquired immune deficiency syndrome patients. Proc Natl Acad Sci USA 1986; 83: 7089–7093
   PubMed Web of Science ®Google Scholar
• Yamada S, DePasquale M, Patlak CS, Cserr HF. Albumin outflow into deep cervical lymph from different regions of rabbit brain. Am J Physiol 1991; 261: H1197–H1204
   PubMed Web of Science ®Google Scholar
• Yu YG, King DS, Shin Y-K. Insertion of a coiled-coil peptide from influenza virus hemagglutinin into membranes. Science 1994; 266: 274–276
   PubMed Web of Science ®Google Scholar
• Zhang L, Looney D, Taub D, Chang SL, Way D, Witte MH, Graves MC, Fiala M. Cocaine opens the blood-brain barrier to HIV-1 invasion. Journal of Neurovirology 1998; 4: 619–626
   PubMed Web of Science ®Google Scholar
• Zidovetzki R, Wang JL, Chen P, Jeyasseelan R, Hofrnan F. Human immunodeficiency virus Tat protein induces interleukin 6 mRNA expression in human brain endothelial cells via protein kinase C- and cAMP-dependent protein kinase pathways. AIDS Res Hum Retroviruses 1998; 14: 825–833
   PubMed Web of Science ®Google Scholar
• Zlokovic BV, Begley DJ, Djuricic BM, Mitrovic DM. Measurement of solute transport across the blood-brain barrier in the perfused guinea pig brain: method and application to N-methyl-α-aminoisobutyric acid. J Neurochem 1986; 46: 1444–1451
   PubMedGoogle Scholar